低饮食可以纠正老年人β-上腺素反应缺陷
1Department of Medicine, University of Western Ontario, London, Canada.
Circulation
|February 1, 1992
概括
低饮食改善了老年人的β-上腺素反应,增强了血管和淋巴细胞的功能. 这种饮食改变可能有助于调节老年人的血压和血管度.
科学领域:
- 心血管生理学心血管生理学
- 老年学是指老年学的学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 衰老与β-上腺体受体响应能力的降低有关,这是一个关键的心血管异常.
- 饮食中的限制以前已经在高血压患者中纠正了β-腺素受体反应缺陷.
研究的目的:
- 调查饮食限制对老年人血管和淋巴细胞β-上腺素反应的影响.
- 为了确定低饮食是否可以纠正与年龄相关的β-上腺功能缺陷.
主要方法:
- 研究了10名年龄较大的正常血压受试者 (56+/- 2岁) 接受高 (每天400meq) 或低 (每天10meq) 饮食.
- 通过最大的异二醇介导血管扩张来评估血管反应.
- 测量了淋巴细胞腺基环酶对异二醇的敏感性.
主要成果:
- 与年轻人相比,在高饮食的老年人中,以异二醇为媒介的最大血管扩张减少了.
- 在老年人中,低饮食显著增加了血管扩张和淋巴细胞腺基环酶敏感性.
- 在低饮食中血压下降,平均动脉压与血管扩张相反相关.
结论:
- 低饮食有效地纠正与衰老相关的血管和淋巴细胞β-上腺素反应受损.
- 饮食修改在老年人血管度的上腺体调节中起着重要作用.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

